Key result
High-fat diet increases adipose PCSK9 protein ~80% in mice, while weight loss lowers serum levels.
Why the study?
Does diet-induced obesity versus hepatic steatosis with weight loss differentially affect serum, hepatic, and adipose tissue PCSK9 levels in murine models of metabolic dysfunction-associated steatotic liver disease?
Does diet-induced obesity versus hepatic steatosis with weight loss differentially affect serum, hepatic, and adipose tissue PCSK9 levels in murine models of metabolic dysfunction-associated steatotic liver disease?
Answers are grounded in this paper and cite their sources.
This preclinical study demonstrates that PCSK9 is expressed across white and brown adipose depots and suggests that adiposity/obesity, rather than hepatic steatosis alone, drives elevated circulating PCSK9 levels in metabolic liver disease.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with obesity. Excess cholesterol, the hepatic and circulating levels of which are regulated by proprotein convertase subtilisin/kexin type 9 (PCSK9), exacerbates MASLD. Data on hepatic and circulating PCSK9 protein expression in MASLD are inconsistent, and PCSK9 levels in different adipose tissues have not been well studied. Here, we used two MASLD mouse models that develop hepatic steatosis, one with weight gain and one with weight loss. These models enable distinguishing between the effects of obesity and MASLD. In the high-fat diet model, hepatic PCSK9 protein was normal. PCSK9 protein was increased in the serum and epididymal fat of the mice. In mice fed a methionine-choline-deficient diet, PCSK9 protein was normal in the liver, brown fat, subcutaneous fat, epididymal, and perirenal adipose tissue. Serum PCSK9 levels were reduced, suggesting that the lower fat mass of these mice contributed to the reduction. It is noteworthy that PCSK9 expression was low in adipocytes compared to hepatocytes. In addition, stromal vascular cells residing within adipose tissue contribute to PCSK9 protein levels in adipose tissue. PCSK9 protein was similar in subcutaneous, epididymal, and perirenal adipose tissue and was lowest in brown adipose tissue, indicating a more prominent expression in white adipose tissues. The current study shows that PCSK9 is expressed in both white and brown adipose tissues, and suggests that obesity rather than liver steatosis is associated with higher serum PCSK9 levels.
No takes yet. Share an insight, caveat, or question.
Krautbauer et al. (2026) studied Metabolic dysfunction-associated steatotic liver disease (MASLD) (n=24). High-fat diet (HFD) or Methionine-choline-deficient (MCD) diet vs. Standard control diet (SD) or MCD control chow was evaluated on PCSK9 protein levels in epididymal adipose tissue (ng PCSK9/mg total protein) (p=0.018). High-fat diet feeding in mice increased serum PCSK9 and epididymal fat PCSK9 protein, whereas a weight-reducing MCD diet lowered serum PCSK9.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: